Cite Filings / WHWK / 0001193125-19-007481
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13D/A

Beneficial Ownership Report

Whitehawk Therapeutics, Inc. · Filed 2019-01-11 · Acc 0001193125-19-007481

Documents 1

  • SC 13D/A Beneficial Ownership Report , d684588dsc13da.htm

Around this filing

  • 2019-03-28 SC 13D/A Beneficial Ownership Report
  • 2019-01-11 SC 13D/A Beneficial Ownership Report
  • 2019-01-10 4 Director bought 63,818 shares at an average $2.35 ($150,290)
  • 2019-01-07 8-K Regulation FD disclosure
  • 2019-01-07 4 Director bought 60,000 shares at an average $2.12 ($127,462)
  • 2018-10-04 SC 13D/A Beneficial Ownership Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G · Dellora Investments LP 5.6%
  2. 2026-11-16 SCHEDULE 13G/A · ABG Global Life Science Capital Partners V GP Limited 7.8%
  3. 2026-11-13 SCHEDULE 13G/A · Coastlands Capital LP 6.19%
Loading d684588dsc13da.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…